$AIFF
FIREFLY NEUROSCIENCE, INC.

2024 Q2 Form 10-Q Financial Statement

#000143774924016602 Filed on May 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.904M $1.915M
YoY Change -5.98% -11.33%
Cost Of Revenue $1.216M
YoY Change -19.11%
Gross Profit $682.7K $699.3K
YoY Change -3.17% 6.46%
Gross Profit Margin 35.86% 36.51%
Selling, General & Admin $1.065M $1.373M
YoY Change -35.64% -14.79%
% of Gross Profit 155.96% 196.38%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $52.43K
YoY Change -3.19%
% of Gross Profit 7.5%
Operating Expenses $1.065M $1.373M
YoY Change -35.64% -14.79%
Operating Profit -$382.1K -$674.0K
YoY Change -177.48% -29.41%
Interest Expense $10.74K
YoY Change -69.69%
% of Operating Profit
Other Income/Expense, Net $2.740K $4.345K
YoY Change 1991.6% 4674.73%
Pretax Income -$389.7K -$674.0K
YoY Change -185.38% -31.93%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$389.7K -$674.0K
YoY Change -265.98% -50.08%
Net Earnings / Revenue -20.47% -35.19%
Basic Earnings Per Share -$0.58 -$0.33
Diluted Earnings Per Share -$0.58 -$0.33
COMMON SHARES
Basic Shares Outstanding 2.013M 2.013M
Diluted Shares Outstanding 671.1K

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $563.3K
YoY Change -30.86%
Cash & Equivalents $244.1K $563.3K
Short-Term Investments
Other Short-Term Assets $220.6K
YoY Change -73.32%
Inventory
Prepaid Expenses
Receivables $791.7K $776.0K
Other Receivables $0.00
Total Short-Term Assets $1.169M $1.560M
YoY Change -55.04% -52.38%
LONG-TERM ASSETS
Property, Plant & Equipment $41.41K $49.63K
YoY Change -47.77% -44.17%
Goodwill $1.125M $1.125M
YoY Change 0.0% 0.0%
Intangibles $927.4K $961.5K
YoY Change -15.21% -15.49%
Long-Term Investments
YoY Change
Other Assets $18.42K $18.42K
YoY Change -10.69% -76.77%
Total Long-Term Assets $2.141M $2.205M
YoY Change -41.31% -45.08%
TOTAL ASSETS
Total Short-Term Assets $1.169M $1.560M
Total Long-Term Assets $2.141M $2.205M
Total Assets $3.310M $3.765M
YoY Change -47.02% -48.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $759.2K $662.3K
YoY Change -9.58% 28.94%
Accrued Expenses $789.2K
YoY Change -33.57%
Deferred Revenue $55.53K $85.04K
YoY Change -22.88% -33.09%
Short-Term Debt $500.0K
YoY Change -60.82%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.915M $2.040M
YoY Change -43.35% -55.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.915M $2.040M
Total Long-Term Liabilities $0.00
Total Liabilities $1.931M $2.056M
YoY Change -46.8% -58.2%
SHAREHOLDERS EQUITY
Retained Earnings -$34.29M -$33.90M
YoY Change 6.14% 4.17%
Common Stock $73.00 $2.180K
YoY Change -99.65% -89.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.379M $1.709M
YoY Change
Total Liabilities & Shareholders Equity $3.310M $3.765M
YoY Change -47.02% -48.36%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$389.7K -$674.0K
YoY Change -265.98% -50.08%
Depreciation, Depletion And Amortization $52.43K
YoY Change -3.19%
Cash From Operating Activities -$118.7K
YoY Change -93.27%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -$118.7K
Cash From Investing Activities $0.00
Cash From Financing Activities $0.00
Net Change In Cash -$118.7K
YoY Change -241.88%
FREE CASH FLOW
Cash From Operating Activities -$118.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
528522 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
484461 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
440991 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
432620 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2180485
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2013180
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2180485
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2013180
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
167305
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
167305
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
0 usd
CY2024Q1 wavd Lease Termination Fee Period Of Rent
LeaseTerminationFeePeriodOfRent
P2M
CY2024Q1 us-gaap Fair Value Asset Liability Recurring Basis Still Held Unrealized Gain Loss
FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss
0 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-41092
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
54-1167364
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
12015 Lee Jackson Memorial Highway, Suite 210
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Fairfax
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
22033
CY2024Q1 dei City Area Code
CityAreaCode
703
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
383-3000
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2024Q1 dei Trading Symbol
TradingSymbol
WAVD
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
36456957 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33899186 usd
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2013180
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
563324 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
681995 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
776025 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1117862 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
220594 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
267351 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
1559943 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2067208 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
961478 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1005539 usd
CY2024Q1 us-gaap Goodwill
Goodwill
1125101 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1125101 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50154 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
245569 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49628 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57999 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18419 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18419 usd
CY2024Q1 us-gaap Assets
Assets
3764723 usd
CY2023Q4 us-gaap Assets
Assets
4519835 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
662318 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
403441 usd
CY2024Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
500000 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
500000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
541777 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
615766 usd
CY2024Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
0 usd
CY2023Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
30223 usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3450 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3450 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
168658 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
267604 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
85035 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
114540 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
78778 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
163282 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2040016 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2098306 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
136652 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
16187 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
16187 usd
CY2024Q1 us-gaap Liabilities
Liabilities
2056203 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2251145 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
2180 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2180 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
36570737 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33225236 usd
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
965211 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
965211 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1708520 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2268690 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3764723 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4519835 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1915372 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2160123 usd
CY2024Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1216114 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1503325 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
699258 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
656798 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1373229 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1611528 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-673971 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-954730 usd
CY2024Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
6419 usd
CY2023Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4345 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
91 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
10743 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
35448 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-673950 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-990087 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 wavd Income Loss From Continuing Operations Net Of Tax Before Equity Method Investments
IncomeLossFromContinuingOperationsNetOfTaxBeforeEquityMethodInvestments
-673950 usd
CY2023Q1 wavd Income Loss From Continuing Operations Net Of Tax Before Equity Method Investments
IncomeLossFromContinuingOperationsNetOfTaxBeforeEquityMethodInvestments
-990087 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-23872 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-673950 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1013959 usd
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-335993 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-673950 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1349952 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.33
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.53
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.17
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.7
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2013180
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1921220
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-673950 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1349952 usd
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-0 usd
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-335993 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
52432 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
54158 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
113780 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
288172 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
29694 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
31717 usd
CY2024Q1 wavd Accretion Of Deferred Acquisition Consideration
AccretionOfDeferredAcquisitionConsideration
0 usd
CY2023Q1 wavd Accretion Of Deferred Acquisition Consideration
AccretionOfDeferredAcquisitionConsideration
20478 usd
CY2024Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
6419 usd
CY2023Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-0 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-0 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-23872 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-341837 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4413 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-46757 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
267033 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
258877 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-60138 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-29505 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-55665 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-172935 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
16672 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-49016 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-50304 usd
CY2024Q1 us-gaap Increase Decrease In Reserve For Commissions Expense And Taxes
IncreaseDecreaseInReserveForCommissionsExpenseAndTaxes
30223 usd
CY2023Q1 us-gaap Increase Decrease In Reserve For Commissions Expense And Taxes
IncreaseDecreaseInReserveForCommissionsExpenseAndTaxes
54810 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-118671 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1071253 usd
CY2024Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 usd
CY2023Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-693106 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-118671 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1764359 usd
CY2024Q1 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 usd
CY2023Q1 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
935974 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
935974 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
575000 usd
CY2024Q1 wavd Proceeds From Premium Financing Borrowing
ProceedsFromPremiumFinancingBorrowing
0 usd
CY2023Q1 wavd Proceeds From Premium Financing Borrowing
ProceedsFromPremiumFinancingBorrowing
305759 usd
CY2024Q1 wavd Repayments Of Premium Financing Borrowings
RepaymentsOfPremiumFinancingBorrowings
-0 usd
CY2023Q1 wavd Repayments Of Premium Financing Borrowings
RepaymentsOfPremiumFinancingBorrowings
29586 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
53453 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7400 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
912026 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-118671 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
83641 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
681995 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
731081 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
563324 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
814722 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
12082 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
18356 usd
CY2024Q1 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
0 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
1263000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2268690 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-673950 usd
CY2023Q1 wavd Cash After Closing
CashAfterClosing
133148 usd
CY2023Q1 wavd Disposal Group Including Discontinued Operation Buyer Stock
DisposalGroupIncludingDiscontinuedOperationBuyerStock
581000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Asset Noncurrent
BusinessCombinationContingentConsiderationAssetNoncurrent
682000 usd
CY2023Q1 wavd Disposal Group Including Discontinued Operation Estimated Fair Value Of Reporting Unit
DisposalGroupIncludingDiscontinuedOperationEstimatedFairValueOfReportingUnit
2332122 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
113780 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1708520 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3729903 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1349952 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
353658 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
407322 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37631 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7400 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2371318 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-673971 usd
CY2024Q1 wavd Working Capital
WorkingCapital
-480073 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
563324 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><span style="text-decoration: underline; ">Use of Estimates</span></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt;">Preparation of condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates due to uncertainties. On an ongoing basis, we evaluate our estimates, including those related to the allowance for credit losses; fair values of financial instruments, intangible assets, and goodwill, including the underlying estimates of cash flows of our products and reporting unit; useful lives of intangible assets and property and equipment; the valuation of stock-based compensation, and the valuation of deferred tax assets and liabilities, among others. We base our estimates on assumptions, both historical and forward looking, that are believed to be reasonable, and the results of which form the basis for making judgments about the carrying values of assets and liabilities.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><span style="text-decoration: underline; ">Concentration of Credit Risk</span></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt;">During the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2024</em>, the Company’s prime contracts with U.S. government agencies represented 8.9%of revenue and subcontracts under federal procurements represented 91.1% of revenue. The terms of these contracts and subcontracts vary from single transactions to <span style="-sec-ix-hidden:c112737913">five</span> years. Three subcontracts under federal procurements represented 29.0%, 23.0%, and 17.0% of revenue, respectively. Revenue from <span style="-sec-ix-hidden:c112737917">one</span> prime contractor under which the Company has multiple subcontracts represented 58.8% of the Company’s revenue in aggregate.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 0pt;">During the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2023</em>, the Company’s prime contracts with U.S. government agencies represented 8.9% of revenue and subcontracts under federal procurements represented 87.7% of revenue, and 3.4% of revenue came from commercial contracts. The terms of these contracts and subcontracts vary from single transactions to <span style="-sec-ix-hidden:c112737923">five</span> years. Three subcontracts under federal procurements represented 31.0%, 24.0%, and 13.9% of revenue, respectively. Revenue from <span style="-sec-ix-hidden:c112737927">one</span> prime contractor under which the Company has multiple subcontracts represented 50.9% of the Company’s revenue in aggregate.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 0pt;">As of <em style="font: inherit;"> March 31, 2024</em>, the Company’s accounts receivable included receivables from three subcontracts under federal procurements that represented 24.0%, 20.7%, and 14.0% of the Company’s outstanding accounts receivable, respectively. Receivables from <span style="-sec-ix-hidden:c112737933">one</span> prime contractor under which the Company has multiple subcontracts represented 51.6% of the Company’s outstanding accounts receivable in aggregate.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt;">As of <em style="font: inherit;"> March 31, 2023</em>, the Company’s accounts receivable included receivables from three subcontracts under federal procurements that represented 41.0%, 12.0%, and 12.5% of the Company’s outstanding accounts receivable, respectively. Receivables from <span style="-sec-ix-hidden:c112737939">one</span> prime contractor under which the Company has multiple subcontracts represented 61.7% of the Company’s outstanding accounts receivable in aggregate.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
935974 usd
CY2021 wavd Lessee Operating Lease Rent Escalations Percentage
LesseeOperatingLeaseRentEscalationsPercentage
0.025 pure
CY2024Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
6419 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045 pure
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
87988 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
29330 usd
CY2023Q1 wavd Sharebased Compensation Arrangement By Sharebased Payment Award Income Previously Recognized As Stocked Based Compensation Expense
SharebasedCompensationArrangementBySharebasedPaymentAwardIncomePreviouslyRecognizedAsStockedBasedCompensationExpense
407322 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1915372 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2160123 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2024Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
776025 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1117862 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
114540 usd
CY2024Q1 wavd Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
26026 usd
CY2024Q1 wavd Contract With Customer Liability Revenue Recognized During Period
ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod
55531 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
85035 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
182756 usd
CY2023Q1 wavd Contract With Customer Liability Revenue Recognized During Period
ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod
55665 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
127091 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
55531 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
55665 usd
CY2024Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
0 usd
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
58658 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
80114 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
80114 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1336 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
78778 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
38719 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
38053 usd
CY2023Q3 wavd Discount Rate Of Project Revenue
DiscountRateOfProjectRevenue
0.4075 pure
CY2023Q1 us-gaap Fair Value Asset Liability Recurring Basis Still Held Unrealized Gain Loss
FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss
0 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
484461 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
44061 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
528522 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
725539 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
44061 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
681478 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1005539 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
44061 usd
CY2024Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
961478 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
308217 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
44061 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
352278 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
901783 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
44061 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
857722 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1181783 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
44061 usd
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1137722 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
102246 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
136248 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
136248 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
136248 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
136248 usd
CY2024Q1 wavd Finitelived Intangible Asset Expected Amortization After Year Four
FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour
34240 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
681478 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
222359 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P14M
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
113780 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
288172 usd
CY2024Q1 wavd Common Stock Purchase Agreement Text Bock
CommonStockPurchaseAgreementTextBock
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-size: 10pt;"><tbody><tr style="vertical-align: top; font-size: 10pt;"><td style="width: 36pt; vertical-align: middle; font-size: 10pt;"> <p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Note <em style="font: inherit;">9.</em></b></p> </td><td style="width: auto; vertical-align: middle; font-size: 10pt;"><b>Sales of Shares Under Common Stock Purchase Agreement</b></td></tr> </tbody></table> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt;">On <em style="font: inherit;"> July 8, 2022, </em>we entered into a Common Stock Purchase Agreement (the “Purchase Agreement” or "ELOC") and a Registration Rights Agreement (the “Registration Rights Agreement”) with B. Riley Principal Capital II, LLC (“B. Riley”). Pursuant to the Purchase Agreement, subject to certain limitations and conditions, the Company has the right, but <em style="font: inherit;">not</em> the obligation, to sell to B. Riley up to $15,000,000 of shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), from time to time. Sales of Common Stock to B. Riley under the Purchase Agreement, and the timing of any such sales, are solely at the Company’s option, and the Company is under <em style="font: inherit;">no</em> obligation to sell any securities to B. Riley under the Purchase Agreement. Pursuant to the Registration Rights Agreement, the Company agreed to file a registration statement with the Securities Exchange Commission (the “SEC”) to register under the Securities Act of <em style="font: inherit;">1933,</em> as amended (the “Securities Act”) the resale by B. Riley of up to 450,000 shares of Common Stock that the Company <em style="font: inherit;"> may </em>issue or elect, in the Company’s sole discretion, to issue and sell to B. Riley, from time to time under the Purchase Agreement. Use of the ELOC is subject to restrictions based on the price and trading volume of our stock, which limits its availability to the Company as a significant source of capital.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt;">During the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2024</em>, the Company had no sales of shares of common stock. During the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2023</em>, the Company sold 7,429 shares of common stock under the ELOC at an average price of $7.20 per share, net of fees of approximately $0.40 per share. The net proceeds from this sale were $53,453.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001437749-24-016602-index-headers.html Edgar Link pending
0001437749-24-016602-index.html Edgar Link pending
0001437749-24-016602.txt Edgar Link pending
0001437749-24-016602-xbrl.zip Edgar Link pending
ex_657124.htm Edgar Link pending
ex_657125.htm Edgar Link pending
ex_657126.htm Edgar Link pending
ex_657127.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pic1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wavd-20240331.xsd Edgar Link pending
wavd20240331c_10q.htm Edgar Link pending
wavd-20240331_cal.xml Edgar Link unprocessable
wavd-20240331_def.xml Edgar Link unprocessable
wavd-20240331_lab.xml Edgar Link unprocessable
wavd-20240331_pre.xml Edgar Link unprocessable
wavd20240331c_10q_htm.xml Edgar Link completed